Tulavi Therapeutics is a privately held company, developing a portfolio of innovative nerve repair products. Tulavi’s innovative Adaptive Hydrogel Technology is engineered to support nerve healing to address poor and unpredictable outcomes in neuroma prevention, adhesion reduction, and nerve repair. The company’s first product, allay™ Nerve Cap with Adaptive Hydrogel Technology is designed to be the first and only fully absorbable in situ technology to protect transected nerves, prevent axonal escape and eliminate neuroma formation.

Tulavi Therapeutics was founded in 2018 by Incept LLC and is funded by several leading venture capital groups.